Clinical Trial Update: Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fecal microbiota transplantation to prevent acute graft-versus-host disease in adults undergoing allogeneic hematopoietic cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Hematologic Neoplasms

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm | Phase 2 | Status: ACTIVE_NOT_RECRUITING